MHRA Drug Safety Update December 2021
Links to the MHRA Drug Safety Update for December 2021 are listed below.
- Haloperidol (Haldol): reminder of risks when used in elderly patients for the acute treatment of delirium
- Venetoclax (Venclyxto▼): updated recommendations on tumour lysis syndrome (TLS)
- Dapagliflozin (Forxiga): no longer authorised for treatment of type 1 diabetes mellitus
- COVID-19 vaccines and medicines: updates for December 2021
You can sign up to receive these alerts directly from the MHRA at: MHRA email alerts
Published 22/12/21. Medicines Update blogs are correct at the time of publication.